戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 8 for interaction of treatment with baseline orthostatic hypotension).
2  Midodrine is an alpha1-agonist approved for orthostatic hypotension.
3 classic orthostatic hypotension, and delayed orthostatic hypotension.
4 mostly influenced by age and the severity of orthostatic hypotension.
5 pheral resistance giving rise to symptomatic orthostatic hypotension.
6 st 30 beats-per-minute upon standing without orthostatic hypotension.
7 c reaction at OFC are common and can include orthostatic hypotension.
8 r other causes, such as vasovagal syncope or orthostatic hypotension.
9 harmacological approach to the management of orthostatic hypotension.
10 oglycerin, 3 neurocardiogenic syncope, and 1 orthostatic hypotension.
11 after having lost these abilities because of orthostatic hypotension.
12                  One subject had evidence of orthostatic hypotension.
13 eral vascular resistance, often resulting in orthostatic hypotension.
14 ents were peripheral oedema, hypotension, or orthostatic hypotension.
15 oreceptor-cardiac reflex function and causes orthostatic hypotension.
16 m serve to protect against the occurrence of orthostatic hypotension.
17  Five of the LBD cases and all MSA cases had orthostatic hypotension.
18 action can be beneficial in the treatment of orthostatic hypotension.
19 ls, anemia, fatigue, nausea or vomiting, and orthostatic hypotension.
20 tive heart failure, cardiac arrhythmias, and orthostatic hypotension.
21 with standing, in the absence of significant orthostatic hypotension.
22 hort over 4 years; of those who died, 52 had orthostatic hypotension.
23 ious and safe in the treatment of neurogenic orthostatic hypotension.
24                        In 9 patients without orthostatic hypotension, 6-[(18)F]fluorodopamine positro
25 bile Ehlers-Danlos syndrome, 213; neurogenic orthostatic hypotension, 86; diabetes type II, 71, mast
26 It might be possible to improve treatment of orthostatic hypotension acutely with water imbibation an
27                           There were 9% with orthostatic hypotension and 5% with standing hypotension
28 gns of sympathetic neurocirculatory failure (orthostatic hypotension and abnormal blood-pressure resp
29 Screening autonomic function tests indicated orthostatic hypotension and confirmed chronic autonomic
30 ide an explanation for the predisposition to orthostatic hypotension and intolerance in well-trained
31                                              Orthostatic hypotension and parasympathetic dysfunction
32                                         Both orthostatic hypotension and postprandial hypotension inc
33 anding than before spaceflight, and in some, orthostatic hypotension and presyncope.
34 betes increases the risk of hypertension and orthostatic hypotension and raises the risk of cardiovas
35                                   Neurogenic orthostatic hypotension and supine hypertension are comm
36 comes in patients with coexistent neurogenic orthostatic hypotension and supine hypertension, clinici
37 isks for patients with coexistent neurogenic orthostatic hypotension and supine hypertension.
38 erapy in patients with coexistent neurogenic orthostatic hypotension and supine hypertension; and the
39 ration, leading to an increased incidence of orthostatic hypotension and syncope.
40 mediate benefits of treatment for neurogenic orthostatic hypotension and the long-term risks of supin
41 pain, anxiety and dysautonomia (particularly orthostatic hypotension and urinary dysfunction).
42                Severe autonomic dysfunction (orthostatic hypotension and/or urinary incontinence with
43 es, head trauma, hypertension in midlife and orthostatic hypotension) and 9 with Level B weaker evide
44 sed a significant increase in heart rate and orthostatic hypotension, and 20% of the nortriptyline-tr
45  with medications, structural heart disease, orthostatic hypotension, and arrhythmias, as well as wit
46 on, delayed blood pressure recovery, classic orthostatic hypotension, and delayed orthostatic hypoten
47 age, sex, race, chronic kidney disease, SBP, orthostatic hypotension, and frailty, with the exception
48 imates of impaired BP stabilization, initial orthostatic hypotension, and orthostatic hypotension are
49 c blood pressure (BP) stabilization, initial orthostatic hypotension, and orthostatic hypotension bas
50    Patients with constitutional hypotension, orthostatic hypotension, and predominant cardioinhibitio
51 re likely to have mild cognitive impairment, orthostatic hypotension, and RBD at baseline, and at pro
52 ients with PD for mild cognitive impairment, orthostatic hypotension, and RBD even at baseline visits
53 to model responses to haemorrhage, to assess orthostatic hypotension, and to evaluate haemodynamic an
54  to Earth, including inordinate tachycardia, orthostatic hypotension, and uncommonly, syncope.
55 zation, initial orthostatic hypotension, and orthostatic hypotension are reported.
56 zation, initial orthostatic hypotension, and orthostatic hypotension based on beat-to-beat blood pres
57 thesis that short-term alcohol intake causes orthostatic hypotension because of an impairment in the
58                                              Orthostatic hypotension, before or in the setting of mor
59  There was no difference in the incidence of orthostatic hypotension between the treatment (11.4% [5
60                                              Orthostatic hypotension can reflect altered activity of
61                        In Parkinson disease, orthostatic hypotension can result from L-dopa treatment
62 e develop autonomic dysfunction, featured by orthostatic hypotension, constipation, hypohidrosis and
63  have uncovered four major subtypes: initial orthostatic hypotension, delayed blood pressure recovery
64                                              Orthostatic hypotension did not occur in PSP subjects or
65                                              Orthostatic hypotension did not predict falls after cont
66 tions and can capture clinically significant orthostatic hypotension during activities of daily livin
67 itational unloading to postural instability, orthostatic hypotension, falls, and fractures.
68                             Low incidence of orthostatic hypotension has been reported for silodosin,
69                Instead, patients with PD and orthostatic hypotension have clear evidence for barorefl
70  and all with Parkinson's disease-associated orthostatic hypotension, have a loss of cardiac sympathe
71 cause mortality among those without baseline orthostatic hypotension (hazard ratio [HR], 0.81; 95% CI
72  0.76-0.86) similarly to those with baseline orthostatic hypotension (HR, 0.83; 95% CI, 0.70-1.00; P
73                                              Orthostatic hypotension in patients with parkinsonism ha
74          Additional options for treatment of orthostatic hypotension include erythropoietin and, surp
75                                              Orthostatic hypotension is a cardinal feature of multipl
76                                              Orthostatic hypotension is an unusually large decrease i
77 use, with the main distinction being whether orthostatic hypotension is neurogenic or non-neurogenic.
78                                              Orthostatic hypotension is relatively uncommon, may be a
79 pertensive crises, hypotensive episodes, and orthostatic hypotension, making it the most difficult fo
80                                      In LBD, orthostatic hypotension may be due primarily to involvem
81                                              Orthostatic hypotension may respond to erythropoietin or
82                                   Neurogenic orthostatic hypotension might be the earliest clinical m
83 The best cluster solution found was based on orthostatic hypotension, mild cognitive impairment, rapi
84 ), urinary tract infections (n=9 [11%]), and orthostatic hypotension (n=8 [10%]).
85 nt (ABPM) as a screening tool for neurogenic orthostatic hypotension (nOH), postprandial hypotension
86                  In patients with neurogenic orthostatic hypotension (NOH), the availability of the s
87                                      Initial orthostatic hypotension occurred in 32.9% (95% CI, 31.2%
88                                              Orthostatic hypotension occurs in more than half of frai
89   Patients with Parkinson's disease (PD) and orthostatic hypotension (OH) (PD+OH) or with pure autono
90 arkinsonism and non-motor features including orthostatic hypotension (OH) and cognitive impairment.
91                       An association between orthostatic hypotension (OH) and mortality has been repo
92                         Review the effect of orthostatic hypotension (OH) and rapid-eye-movement slee
93                                         Four orthostatic hypotension (OH) groups were defined based o
94  rivastigmine is affected by the presence of orthostatic hypotension (OH) in patients with Parkinson'
95                                              Orthostatic hypotension (OH) is a common cardiovascular
96                                              Orthostatic hypotension (OH) is a common cause of transi
97                                              Orthostatic hypotension (OH) is a fall in blood pressure
98                                              Orthostatic hypotension (OH) is common in elderly people
99                                              Orthostatic hypotension (OH) is common in older people.
100                                 Drug-induced orthostatic hypotension (OH) is common, and its resultin
101                                              Orthostatic hypotension (OH), a common, often overlooked
102 sed on HUT results, we divided patients into orthostatic hypotension (OH), postural tachycardia syndr
103 ease, there are concerns that it might cause orthostatic hypotension (OH).
104                                              Orthostatic hypotension (OH, 3 vs. 23%, P < 0.001), caro
105 n the heart and other organs, manifesting as orthostatic hypotension (OH; also known as postural hypo
106 available concerning the predictive value of orthostatic hypotension on mortality in ambulatory elder
107                                Patients with orthostatic hypotension or absent sympathetic skin respo
108 itation on return, no astronauts experienced orthostatic hypotension or intolerance during routine (f
109                     No crew member exhibited orthostatic hypotension or presyncopal symptoms during t
110 od pressure (BP) treatment among adults with orthostatic hypotension or standing hypotension.
111 ve supranuclear palsy if a patient developed orthostatic hypotension or urinary incontinence with the
112 cterised by autonomic failure, manifested as orthostatic hypotension or urogenital dysfunction, with
113                 A total of 171 patients with orthostatic hypotension participated in a multicenter, r
114 measured in patients with PD with or without orthostatic hypotension (PD+OH, PD-No-OH); in patients w
115                           Whereas neurogenic orthostatic hypotension poses risks for falls and can be
116 h vibration perception thresholds (VPTs) and orthostatic hypotension (pre-PT and 6 mo, 2-3, 5-6, and
117 tic intolerance symptoms was assessed by the Orthostatic Hypotension Questionnaire (OHQ), consisting
118 ve patients had mild-moderate hypotension or orthostatic hypotension recorded adverse events.
119  or autonomic failure in Parkinson disease), orthostatic hypotension reflects sympathetic neurocircul
120     Establishing whether symptoms are due to orthostatic hypotension requires careful history taking,
121 r adults include gait and balance disorders, orthostatic hypotension, sensory impairment, medications
122 uncomplicated faint, situational syncope, or orthostatic hypotension should receive electrocardiograp
123 lower handgrip strength, hearing impairment, orthostatic hypotension, stroke, diabetes, heart disease
124 n, upper gastrointestinal tract dysfunction, orthostatic hypotension, sweating abnormalities, or erec
125 gene encoding alpha-synuclein, also features orthostatic hypotension, sympathetic neurocirculatory fa
126 llenges, including changes in posture (e.g., orthostatic hypotension, syncope) and physical activity.
127                                              Orthostatic hypotension, syncope, dyskinesia, hallucinat
128 apeutic requirements for managing neurogenic orthostatic hypotension that manifests with falls or cog
129  standing blood pressure assessments, 9% had orthostatic hypotension (that is, a drop in blood pressu
130 supine hypertension when treating neurogenic orthostatic hypotension; the effectiveness of nocturnal
131 usion from cardiac arrest, heart failure, or orthostatic hypotension to AD pathology, while atheroscl
132 e symptomatic autonomic failure (symptomatic orthostatic hypotension, urinary incontinence, or both)
133 perechogenicity, olfactory loss, depression, orthostatic hypotension, urinary/erectile dysfunction, P
134   There was no effect by center, severity of orthostatic hypotension, use of fludrocortisone or compr
135 sk factors were identified across 6 domains: orthostatic hypotension, visual impairment, impairment o
136                            The prevalence of orthostatic hypotension was 6.9% (95% CI, 5.9%-7.8%) in
137                        Overall prevalence of orthostatic hypotension was 6.9% and increased with age.
138 t stroke, coronary heart disease and cancer, orthostatic hypotension was a significant independent pr
139 Program's fourth examination (1991 to 1993), orthostatic hypotension was assessed in relation to subs
140                                              Orthostatic hypotension was defined as a decrease in sys
141                                              Orthostatic hypotension was defined as a drop in systoli
142                                              Orthostatic hypotension was most prevalent before breakf
143 ed mortality rates in those with and without orthostatic hypotension were 56.6 and 38.6 per 1000 pers
144 ous events, two of which (hallucinations and orthostatic hypotension) were deemed related to study dr
145 , urinary symptoms, erectile dysfunction and orthostatic hypotension) were noted.
146  migraine and chronic vascular issues (e.g., orthostatic hypotension) were often misclassified, impac
147 ay contribute to the increased prevalence of orthostatic hypotension with age.
148  of CVD or all-cause mortality regardless of orthostatic hypotension without evidence for different e

 
Page Top